DE602006018619D1 - Zusammensetzungen zur behandlung von luminalen entzündlichen erkrankungen - Google Patents

Zusammensetzungen zur behandlung von luminalen entzündlichen erkrankungen

Info

Publication number
DE602006018619D1
DE602006018619D1 DE602006018619T DE602006018619T DE602006018619D1 DE 602006018619 D1 DE602006018619 D1 DE 602006018619D1 DE 602006018619 T DE602006018619 T DE 602006018619T DE 602006018619 T DE602006018619 T DE 602006018619T DE 602006018619 D1 DE602006018619 D1 DE 602006018619D1
Authority
DE
Germany
Prior art keywords
compositions
cees
luminous
treatment
inflammatory diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006018619T
Other languages
English (en)
Inventor
Gilbert R Gonzales
Nicolas Chronos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Clear Vascular Inc
Original Assignee
Clear Vascular Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clear Vascular Inc filed Critical Clear Vascular Inc
Publication of DE602006018619D1 publication Critical patent/DE602006018619D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/087—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being an annexin, e.g. annexin V
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1027—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against receptors, cell-surface antigens or cell-surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Radiation-Therapy Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE602006018619T 2005-07-20 2006-07-13 Zusammensetzungen zur behandlung von luminalen entzündlichen erkrankungen Active DE602006018619D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70137105P 2005-07-20 2005-07-20
PCT/US2006/027526 WO2007015774A2 (en) 2005-07-20 2006-07-13 Methods and compositions for treating luminal inflammatory disease

Publications (1)

Publication Number Publication Date
DE602006018619D1 true DE602006018619D1 (de) 2011-01-13

Family

ID=37709042

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006018619T Active DE602006018619D1 (de) 2005-07-20 2006-07-13 Zusammensetzungen zur behandlung von luminalen entzündlichen erkrankungen

Country Status (6)

Country Link
US (3) US7874975B2 (de)
EP (1) EP1909901B8 (de)
AT (1) ATE489994T1 (de)
DE (1) DE602006018619D1 (de)
ES (1) ES2353532T3 (de)
WO (1) WO2007015774A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7874975B2 (en) * 2005-07-20 2011-01-25 Clear Vascular, Inc. Methods and compositions for treating luminal inflammatory disease
US8283167B2 (en) * 2009-02-11 2012-10-09 Clear Vascular Inc. Preparation of annexin derivatives
JP2016522832A (ja) * 2013-05-23 2016-08-04 ニューロエスエヌ・インコーポレイテッド 放射性核種で標識したアネキシンを使用したアルツハイマー病の診断及び治療

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4647445A (en) 1984-03-28 1987-03-03 Massachusetts Institute Of Technology Radiolabelled lipoproteins and method for making same
US4937067A (en) 1984-12-13 1990-06-26 Massachusetts Institute Of Technology Method and means for detection of adrenal metabolic activity
US4660563A (en) 1984-12-31 1987-04-28 Massachusetts Institute Of Technology Method and means for detection of arterial lesions
US5225181A (en) 1985-06-07 1993-07-06 The Research Foundation Of State University Of New York Radiolabeled antiplatelet monoclonal antibody for imaging in-vivo thrombi
US4877599A (en) 1986-11-10 1989-10-31 New England Deaconess Hospital Corporation Detection of vascular disease with labelled antibodies
US5726153A (en) 1988-05-02 1998-03-10 New England Deaconess Hospital Corporation Synthetic peptides for arterial imaging
EP0413766A4 (en) 1988-05-02 1991-11-21 New England Deaconess Hospital Corporation Synthetic peptides for arterial imaging
CA1340977C (en) 1988-11-15 2000-04-25 Monty Krieger Scavenger receptor protein and antibody thereto
US5334729A (en) 1989-06-29 1994-08-02 Associated Universities, Inc. Stable radiometal antibody immunoconjugates
US5216130A (en) * 1990-05-17 1993-06-01 Albany Medical College Complex for in-vivo target localization
US7238340B1 (en) 1991-11-27 2007-07-03 Cis Bio International Monoamine, diamide, thiol-containing metal chelating agents
DK0630265T3 (da) 1992-03-13 2003-06-30 Diatide Inc Technetium-99m mærkede peptider til afbildning af inflammation
US5292938A (en) 1992-04-13 1994-03-08 Associated Universities, Inc. Synthesis of 4-substituted-trans-1, 2-diaminocyclohexyl polyaminocarboxylate metal chelating agents for the preparation of stable radiometal antibody immunoconjugates for therapy and spect and pet imaging
US5429133A (en) 1992-12-18 1995-07-04 Neoprobe Corporation Radiation responsive laparoscopic instrument
US5428156A (en) 1993-04-02 1995-06-27 Associated Universities, Inc. Synthesis of macrocyclic polyaminocarboxylates and their use for preparing stable radiometal antibody immunoconjugates for therapy, spect and pet imaging
US5968477A (en) 1994-01-24 1999-10-19 Neorx Corporation Radiolabeled annexin conjugates with hexose and a chelator
JP3122319B2 (ja) * 1994-05-02 2001-01-09 アソシエーティド ユニバーシティーズ，インコーポレイティド 錫−１１７ｍ−含有放射性治療剤
US5783169A (en) 1995-07-26 1998-07-21 Brookhaven Science Associates Llc Rigid bifunctional chelating agents
US5811814A (en) 1996-02-12 1998-09-22 Cordis Corporation Radiation measuring catheter apparatus and method
WO1998048699A1 (en) 1997-04-30 1998-11-05 The Board Of Trustees Of The Leland Stanford Junior University Method of imaging cell death in vivo
US6500108B1 (en) 1999-10-22 2002-12-31 The Regents Of The University Of California Radiation delivery system and method
JP2004530654A (ja) * 2001-02-23 2004-10-07 ブリストル−マイヤーズ・スクイブ・ファーマ・カンパニー アテローム硬化症および脆弱性プラークを画像診断するための標識マクロファージスカベンジャー受容体拮抗薬
US20030103995A1 (en) * 2001-06-04 2003-06-05 Hamblin Michael R. Detection and therapy of vulnerable plaque with photodynamic compounds
US6549802B2 (en) 2001-06-07 2003-04-15 Varian Medical Systems, Inc. Seed localization system and method in ultrasound by fluoroscopy and ultrasound fusion
US20030152513A1 (en) 2001-09-06 2003-08-14 Imetrix, Inc. Intravascular delivery of therapeutic and imaging agents to stressed and apoptotic cells using annexin V as a targeting vector
US7874975B2 (en) * 2005-07-20 2011-01-25 Clear Vascular, Inc. Methods and compositions for treating luminal inflammatory disease

Also Published As

Publication number Publication date
EP1909901B8 (de) 2011-02-02
US20140212356A1 (en) 2014-07-31
US20110077211A1 (en) 2011-03-31
EP1909901A4 (de) 2009-09-23
US7874975B2 (en) 2011-01-25
EP1909901A2 (de) 2008-04-16
US20070021641A1 (en) 2007-01-25
ATE489994T1 (de) 2010-12-15
ES2353532T3 (es) 2011-03-02
WO2007015774A3 (en) 2007-11-01
WO2007015774A2 (en) 2007-02-08
US9283290B2 (en) 2016-03-15
EP1909901B1 (de) 2010-12-01
US8753255B2 (en) 2014-06-17

Similar Documents

Publication Publication Date Title
CY1125077T1 (el) Αγωγη της ανεπαρκειας και ελλειψης βιταμινης d με 25-υδροξυβιταμινη d2 και 25-υδροξυβιταμινη d3
LTPA2016034I1 (lt) Brutono tirozinkinazės inhibitoriai
CY1115289T1 (el) Μεθοδοι αγωγης εναντι ασθενειας που σχετιζεται με φλεγμονη
MA33806B1 (fr) Inhibiteurs du virus de l'hepatite c
MX361467B (es) Compuestos de isoindolina para uso en el tratamiento de cancer.
EA200802213A1 (ru) Способы лечения заболеваний крови
EA200870254A1 (ru) Способ лечения воспалительных заболеваний
MX2010002498A (es) Metodos para tratar o prevenir la infeccion del tracto respiratorio que comprende la administracion de colecalciferol.
ATE497770T1 (de) Pharmazeutische formulierungen von decitabin
RS53236B (en) BETA-AMYLOIDOSIS PEPTIDES
NO20074999L (no) Metode og preparat for behandling av perifere vaskulaere sykdommer
MY155649A (en) Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
MY157661A (en) Bendamustine pharmaceutical compositions
NO20064547L (no) Fremgangsmater for behandling av HIV infeksjon
CY1113824T1 (el) Ενδορινικες συνθεσεις
ATE531419T1 (de) Vorrichtung zur verabreichung von therapeutischen mitteln
UA94036C2 (ru) Фармацевтическая композиция бендамустина, предназначенная для лиофилизации
UY30158A1 (es) Uso de derivados de benzo-heteroaril sulfamida para el tratamiento del dolor
ECSP045397A (es) 6-ALQUILIDEN-PENEMS BICÍCLICOS COMO INHIBIDORES DE LAS b-LACTAMASAS
EA200900095A1 (ru) Лекарственные формы бифосфонатов для ингаляции и способы их применения
NO20076405L (no) Anvendelse av 24-nor-UDCA
MX2009003301A (es) Novedoso inmunogeno neutralizante (nimiv) de rhinovirus y su uso para aplicaciones de vacunas.
DE60320398D1 (de) Methoden und medizinische zusammensetzungen zur intravesikalen behandlung von blasenkrebs
DE602004018119D1 (de) Vorrichtung zur wirkstofffreisetzung mit einer netzhülse
DE602006018619D1 (de) Zusammensetzungen zur behandlung von luminalen entzündlichen erkrankungen

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: CLEAR VASCULAR, INC., THE WOODLANDS, TEX., US